Company

COMPANY OVERVIEW

Trade aceRNA Technologies Co., Ltd.
CEO Fumihiro Sugawa
External Directors Hirohide Saito (Kyoto University Professor), Nobuhiro Yagi (Kyoto University Innovation Capital Co., Ltd.), Takeshi Ueda (Nitto Denko Corporation), Mikihiko Shinozaki (Mitsubishi UFJ Capital Co., Ltd.)
Establishment April 2018
Corporate Vision Contribute to Regenerative Medicine and Drug Development through the discovery of novel miRNA applications.
Mission To eradicate untreatable diseases.
Capital JPY 30,000,000
Address Innovation Hub Kyoto, 46-29 Yoshida Shimoichi-cho, Sakyo-ku, Kyoto 606-8304 JAPAN
Number of Employees 12